2m 2m 2m 2m 2m 2m 2m
TAKEDA PHARM SP ADR (TAK)
NYSE
$18.14-$0.04 (-0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $58.1BMarket Cap
- 21.83%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TAKEDA PHARM SP ADR (TAK)
$18.14-$0.04 (-0.22%)
TAK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.18 | ||
Change | +$0.05 (+0.28%) | ||
Open | $18.09 | ||
High | $18.25 | ||
Low | $18.08 | ||
Previous Close | $18.13 | ||
Volume | 1,479,068 | ||
30-Day Average Volume | 3,626,197 | ||
1-Week Change | 3.12% | ||
1-Month Change | 5.51% | ||
1-Year Change | 21.83% | ||
3-Year Change | 37.13% | ||
5-Year Change | 35.37% | ||
Fundamentals | |||
Shares Outstanding | 3.2B | ||
Total Assets | $15.5T | ||
Market Cap | $58.1B | ||
Enterprise Value | -$537.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 8.48% | ||
Trailing Annual Dividend Yield | 3.47% | ||
Ex-Dividend Date | 03/31/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield